We are now starting to see that the costs of these diseases is huge. They not only occur in settings of poverty, but are poverty promoting as well.

There are no simple answers. The best strategy we have is to foster public-private partnerships, and ensure what the (Bill and Melinda) Gates Foundation calls 'global access' -- not just making the drug but making sure it's used.